[go: up one dir, main page]

AU2002224596A1 - Preventives or remedies for obesity or fatty liver - Google Patents

Preventives or remedies for obesity or fatty liver

Info

Publication number
AU2002224596A1
AU2002224596A1 AU2002224596A AU2459602A AU2002224596A1 AU 2002224596 A1 AU2002224596 A1 AU 2002224596A1 AU 2002224596 A AU2002224596 A AU 2002224596A AU 2459602 A AU2459602 A AU 2459602A AU 2002224596 A1 AU2002224596 A1 AU 2002224596A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
obesity
fatty liver
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224596A
Inventor
Seijiro Hara
Teruo Shiomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2002224596A1 publication Critical patent/AU2002224596A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002224596A 2000-08-01 2001-07-30 Preventives or remedies for obesity or fatty liver Abandoned AU2002224596A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-233072 2000-08-01
JP2000233072 2000-08-01
PCT/JP2001/006532 WO2002009757A1 (en) 2000-08-01 2001-07-30 Preventives or remedies for obesity or fatty liver

Publications (1)

Publication Number Publication Date
AU2002224596A1 true AU2002224596A1 (en) 2002-02-13

Family

ID=18725654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224596A Abandoned AU2002224596A1 (en) 2000-08-01 2001-07-30 Preventives or remedies for obesity or fatty liver

Country Status (7)

Country Link
US (1) US20030153513A1 (en)
EP (2) EP1306094A4 (en)
KR (1) KR20030036658A (en)
CN (1) CN1466465A (en)
AU (1) AU2002224596A1 (en)
CA (1) CA2417492A1 (en)
WO (1) WO2002009757A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512359A (en) * 2003-11-19 2007-05-17 メタバシス・セラピューティクス・インコーポレイテッド Novel phosphorus-containing thyroid hormone-like substance
AU2006249350B2 (en) 2003-11-19 2012-02-16 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
US20090028925A1 (en) * 2005-05-26 2009-01-29 Erion Mark D Novel Phosphinic Acid-Containing Thyromimetics
US8524212B2 (en) * 2007-10-24 2013-09-03 Mitsubishi Tanabe Pharma Corporation Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis
CA2711673A1 (en) * 2008-01-31 2009-08-06 Astellas Pharma Inc. Pharmaceutical compositions for treating fatty liver disease
US9006285B2 (en) 2008-09-30 2015-04-14 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for hepatitis C
WO2010062861A2 (en) * 2008-11-26 2010-06-03 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of obesity and diabetes
ES2552657T3 (en) 2010-05-26 2015-12-01 Satiogen Pharmaceuticals, Inc. Inhibitors of the recycling of bile acids and satiogens for the treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
JP6158720B2 (en) * 2014-02-19 2017-07-05 国立大学法人神戸大学 Surface treatment agent, surface-treated polyamide reverse osmosis membrane and method for producing the same
CN106176800B (en) * 2016-07-11 2019-12-06 韩源平 Pharmaceutical application of polycation resin
KR20190104524A (en) 2016-11-21 2019-09-10 바이킹 테라퓨틱스 인코포레이티드 Treatment method of sugar accumulation disease
EA201992703A1 (en) 2017-06-05 2020-04-15 Вайкинг Терапьютикс, Инк. COMPOSITIONS FOR TREATING FIBROSIS
KR101844184B1 (en) * 2017-07-21 2018-04-02 씨제이헬스케어 주식회사 Use of an aminoalkylbenzothiazepine derivative
KR20200138283A (en) 2018-03-22 2020-12-09 바이킹 테라퓨틱스 인코포레이티드 Crystalline forms, and methods of preparing compounds in crystalline form
US12102646B2 (en) 2018-12-05 2024-10-01 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209138A (en) * 1969-06-13 1970-10-21 Pharma Chemie IMPROVEMENTS IN OR RELATING TO A NEW alpha-NAPHTHOXY-ISOBUTYRIC ACID DERIVATIVE, PROCESS FOR ITS PREPARATION AND THERAPEUTICAL COMPOSITION CONTAINING SAME
IT1052819B (en) * 1975-12-12 1981-07-20 Fargal Pharmasint Lab Biochim DIETHYLAMIN ETHYL DEXTRANE-BASED LIPID ABSORPTION INHIBITOR PREPARATION
DE69228262D1 (en) * 1991-10-17 1999-03-04 Shionogi & Co Process for the preparation of lignin analogues and starting materials therefor
JP3556962B2 (en) * 1993-03-30 2004-08-25 雪印乳業株式会社 Fatty liver inhibitor
JPH09241206A (en) * 1996-03-01 1997-09-16 Shionogi & Co Ltd Lignan compound
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis

Also Published As

Publication number Publication date
EP1306094A1 (en) 2003-05-02
US20030153513A1 (en) 2003-08-14
CN1466465A (en) 2004-01-07
EP1749539A2 (en) 2007-02-07
CA2417492A1 (en) 2003-01-28
EP1306094A4 (en) 2006-04-12
WO2002009757A1 (en) 2002-02-07
KR20030036658A (en) 2003-05-09

Similar Documents

Publication Publication Date Title
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2002246666A1 (en) Anti-icing composition
AU2473401A (en) Organosiloxane compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2001230894A1 (en) Pro-perfume composition
AU2001241095A1 (en) Preventives and/or remedies for hyperphosphatemia
AU2002224596A1 (en) Preventives or remedies for obesity or fatty liver
AU1530001A (en) Inhibitor compositions
AUPQ875700A0 (en) Combination compositions
AU2002214324A1 (en) Medicinal compositions
AU2001249675A1 (en) Fatty quat based on ante-iso compounds
AU2001241098A1 (en) Composition
AU2001273919A1 (en) Pharmaceutical compositions
AU3987800A (en) Preventives/remedies for angiostenosis
AU2002222676A1 (en) Preventives or remedies for endometriosis
AU2001232271A1 (en) Preventives/remedies for postoperative stress
AU2002224133A1 (en) Remedies for dermatophytosis
AU2000278051A1 (en) Stabilized emulsion compositions
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001235764A1 (en) Compositions
AU2001275043A1 (en) Mineral supplement
AU2002359916A1 (en) Preventives/remedies for cancer
AU2003236039A1 (en) Preventives/remedies for hotflash